DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Dapansutrile
Dapansutrile
PRODUCT INFORMATION Dapansutrile Item No
ATP-Binding and Hydrolysis in Inflammasome Activation
Modulation of the Inflammatory Response After Spinal Cord Injury
Charles A. Dinarello, MD
Development of Covalent NLRP3 Inflammasome Inhibitors: Chemistry and Biological Activity
Inhibitory Effects of Shiitake-Derived Exosome-Like Nanoparticles on NLRP3 Inflammasome Activation" (2019)
NLRP3 Inflammasome Inhibitors in Cardiovascular Diseases
Product Data Sheet
Current and Pipeline NLRP3 Inhibitors
Implications for Circadian Medicine
Free PDF Download
Inflammasome Activation at the Crux of Severe COVID-19
The NLRP3 Inflammasome and Its Role in the Pathogenicity of Leukemia
Targeting the NLRP3 Inflammasome in Severe COVID-19
NOD-Like Receptor (NLR)
Targeting of the NLRP3 Inflammasome for Early COVID-19 2 3 4 Carlo Marchetti1*, Kara Mould2, Isak W
A Possible Therapeutic Approach for Periodontal Disease (Review)
Novartis Trial Validates Inflammasome As Chronic Disease Driver
Top View
Consulter Le Manuscrit
The NLRP3 Inflammasome Inhibitor OLT1177 Rescues Cognitive Impairment in a Mouse Model of Alzheimer’S Disease
Novel Experimental Strategies to Treat Multiple Sclerosis
Promise of the NLRP3 Inflammasome Inhibitors in in Vivo Disease Models
2018 Medicines in Development for Neurological Disorders a Report on Disorders of the Brain, Spinal Cord and Nerves
Medical Product Quality Report – COVID-19 Issues
News & Analysis
Pharmacological Inhibition of the Nod-Like Receptor Family Pyrin Domain Containing 3 Inflammasome with MCC950
The Effects of an Inflammasome Inhibitor OLT1177 on the Development of Ischemic Heart Failure
Inhibiting the NLRP3 Inflammasome
WO 2018/129231 Al 12 July 2018 (12.07.2018) W !P O PCT
A Selective NLRP3 Inflammasome Inhibitor, Ameliorates Experimental
Inflammasome NLRP3 Potentially Links Obesity-Associated
Dapansutrile (OLT1177)